By Anthony O. Goriainoff
Intelligent Ultrasound Group PLC said Friday that an ultrasound machine using its technology has received premarket clearance from the Food and Drug Administration for sale in the U.S.
The London-listed developer of AI-based ultrasound and simulation software said GE Healthcare's Voluson SWIFT ultrasound machine incorporates GE Healthcare's SonoLyst software with Intelligent Ultrasound's ScanNav Assist AI technology.
The company said SonoLyst is the first artificial-intelligence software to be launched under its long-term license and co-development agreement with GE Healthcare, and that the first royalty per unit revenues are expected at the start of 2021.
"SonoLyst is an exciting new scanning aid in women's healthcare and FDA clearance for the Voluson SWIFT opens up the important U.S. market," the company said.
Write to Anthony O. Goriainoff at firstname.lastname@example.org
(END) Dow Jones Newswires